Roivant Social Ventures announced a six-figure organizational legacy gift to No Patient Left Behind, according to an October 29 headline. The supplied information does not give the exact amount, timing, or intended use of the gift, or explain whether it will affect Roivant Sciences’ finances or operations. ROIV.US shares closed at US$37.09, up 1.10% for the day.
Investor takeaway: The announcement confirms a six-figure gift from Roivant Social Ventures to No Patient Left Behind. The available details do not show what it means for Roivant Sciences’ business or financial results.
Roivant Sciences closed at US$37.09
Roivant Sciences Ltd
ROIV.US
ROIV.US
Roivant Sciences Ltd
WealthAwesomeMarket cap
$26.81B
52W high
$42.50
52W low
$19.30
1W change
+0.19%
Beta
1.10
Analyst Price Targets
Based on 13 analysts covering ROIV · as of Oct 23, 2026
Wall Street analysts forecast ROIV stock price to rise 30.4% over the next 12 months.
Consensus
Strong Buy4.54 / 5.00
Avg. Target
C$48.91
+30.4% Upside
Previously C$48.27 on Oct 19, 2026
Current Price
C$37.52
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ROIV's historical volatility
30-Day Vol
35.8%
Annualized
90-Day Vol
44.7%
Annualized
Trend (90d)
+34.0%
Annualized drift
90d Mean
C$42.37
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$39.07 | C$34.54 – C$44.20 |
| 60 trading days | C$40.69 | C$34.17 – C$48.44 |
| 90 trading days | C$42.37 | C$34.22 – C$52.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Shares rose 1.10% on the day. Trading volume was 504,743 shares, compared with a 20-day average of 6,566,418.
Bull case
The announcement confirms that Roivant Social Ventures is making a six-figure organizational gift to No Patient Left Behind.
Bear case
The headline does not state the gift’s exact amount, funding source, or expected effect on Roivant Sciences.
What happened: a six-figure organizational legacy gift
An October 29 headline says Roivant Social Ventures announced a six-figure organizational legacy gift to No Patient Left Behind. It does not specify the amount, when the gift will be delivered, how the recipient will use it, or whether Roivant Sciences will report a related financial effect. Other supplied headlines cover a different company and an ETF, so they add no details about this gift. For company background and its listing, see Roivant Sciences’ stock page.
What the numbers show for Roivant Sciences
Roivant Sciences closed at US$37.09, up 1.10% for the day and 0.19% over the week. Shares gained 2.79% over the month and 71.09% year to date, based on the supplied figures. Trading volume was 504,743 shares, or 0.57 times the 20-day average of 6,566,418. These figures describe the stock; the available information does not show that the gift caused the daily move. The company’s market capitalization was about US$26.8 billion. Reported trailing EPS was -US$0.53, and profit margin was 0.0%. See the ROIV stock page for more company data.
What to watch next: details on the gift
The announcement leaves several questions open: the gift’s exact value, timing, intended use, and any financial or operational implications for Roivant Sciences. Those details would clarify its scope. For now, the headline confirms only that Roivant Social Ventures announced a six-figure organizational legacy gift to No Patient Left Behind. It does not establish a measurable effect on Roivant Sciences’ business or results.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
